Serum chemerin and high-sensitivity C reactive protein as markers of subclinical atherosclerosis in Egyptian patients with type 2 diabetes

Context: Chemerin is one of the adipokines that regulate fat metabolism. High-sensitivity C-reactive protein (hs-CRP) may be considered as a cardiovascular risk predictor. Measuring intima-media thickness of the CCA (C-IMT) is a well-evidenced tool for the detection of early stages of atherosclerosi...

Full description

Bibliographic Details
Main Authors: Nagwa A. Lachine, Abdel Aziz Elnekiedy, Magdy Helmy Megallaa, Gihane I. Khalil, Mohamed A. Sadaka, Kamel H. Rohoma, Heba S. Kassab
Format: Article
Language:English
Published: SAGE Publishing 2016-04-01
Series:Therapeutic Advances in Endocrinology and Metabolism
Online Access:https://doi.org/10.1177/2042018816637312
id doaj-6c337647829e466d8e66060d87ef0954
record_format Article
spelling doaj-6c337647829e466d8e66060d87ef09542020-11-25T03:23:37ZengSAGE PublishingTherapeutic Advances in Endocrinology and Metabolism2042-01882042-01962016-04-01710.1177/2042018816637312Serum chemerin and high-sensitivity C reactive protein as markers of subclinical atherosclerosis in Egyptian patients with type 2 diabetesNagwa A. LachineAbdel Aziz ElnekiedyMagdy Helmy MegallaaGihane I. KhalilMohamed A. SadakaKamel H. RohomaHeba S. KassabContext: Chemerin is one of the adipokines that regulate fat metabolism. High-sensitivity C-reactive protein (hs-CRP) may be considered as a cardiovascular risk predictor. Measuring intima-media thickness of the CCA (C-IMT) is a well-evidenced tool for the detection of early stages of atherosclerosis. We aimed here to study both serum chemerin and hs-CRP as markers of subclinical atherosclerosis in Egyptian patients with type 2 diabetes, who are angiographically free of coronary artery disease (CAD). Subjects and methods: This cross-sectional study was conducted on 180 subjects divided into two groups: Group A included 90 type 2 diabetic patients without CAD and group B including 90 nondiabetic control subjects. All study subjects were having normal coronary angiography. Serum chemerin, homeostasis model assessment for insulin resistance (HOMA-IR), glycated haemoglobin (HbA1c), lipid profile, hs-CRP as well as C-IMT were assessed in all study subjects. Results: There was a statistically significant difference between the 2 groups regarding serum chemerin level, HOMA-IR, hs-CRP and C-IMT; being higher in the diabetic patients than in the control group ( p = 0.006, 0.024, 0.040 and <0.001, respectively). There was positive correlation between serum chemerin level and waist-to-hip ratio (WHR), HOMA-IR, hs-CRP and C-IMT. Carotid intima-media thickness was positively correlated with patients’ WHR, blood pressure, HbA1c, diabetes duration as well as hs-CRP, and negatively correlated with ankle-brachial index (ABI). Linear regression analysis showed that HbA1c, serum chemerin and hs-CRP were independently affecting C-IMT. Serum hs-CRP was positively correlated with HbA1c and HOMA-IR ( p = 0.006 and 0.032, respectively), and negatively correlated with HDL-cholesterol level ( p = 0.018). Conclusion: Both serum chemerin and hs-CRP could be considered as markers of subclinical atherosclerosis, and hence, may be utilized for the early detection of macrovascular disease, in Egyptian patients with type 2 diabetes.https://doi.org/10.1177/2042018816637312
collection DOAJ
language English
format Article
sources DOAJ
author Nagwa A. Lachine
Abdel Aziz Elnekiedy
Magdy Helmy Megallaa
Gihane I. Khalil
Mohamed A. Sadaka
Kamel H. Rohoma
Heba S. Kassab
spellingShingle Nagwa A. Lachine
Abdel Aziz Elnekiedy
Magdy Helmy Megallaa
Gihane I. Khalil
Mohamed A. Sadaka
Kamel H. Rohoma
Heba S. Kassab
Serum chemerin and high-sensitivity C reactive protein as markers of subclinical atherosclerosis in Egyptian patients with type 2 diabetes
Therapeutic Advances in Endocrinology and Metabolism
author_facet Nagwa A. Lachine
Abdel Aziz Elnekiedy
Magdy Helmy Megallaa
Gihane I. Khalil
Mohamed A. Sadaka
Kamel H. Rohoma
Heba S. Kassab
author_sort Nagwa A. Lachine
title Serum chemerin and high-sensitivity C reactive protein as markers of subclinical atherosclerosis in Egyptian patients with type 2 diabetes
title_short Serum chemerin and high-sensitivity C reactive protein as markers of subclinical atherosclerosis in Egyptian patients with type 2 diabetes
title_full Serum chemerin and high-sensitivity C reactive protein as markers of subclinical atherosclerosis in Egyptian patients with type 2 diabetes
title_fullStr Serum chemerin and high-sensitivity C reactive protein as markers of subclinical atherosclerosis in Egyptian patients with type 2 diabetes
title_full_unstemmed Serum chemerin and high-sensitivity C reactive protein as markers of subclinical atherosclerosis in Egyptian patients with type 2 diabetes
title_sort serum chemerin and high-sensitivity c reactive protein as markers of subclinical atherosclerosis in egyptian patients with type 2 diabetes
publisher SAGE Publishing
series Therapeutic Advances in Endocrinology and Metabolism
issn 2042-0188
2042-0196
publishDate 2016-04-01
description Context: Chemerin is one of the adipokines that regulate fat metabolism. High-sensitivity C-reactive protein (hs-CRP) may be considered as a cardiovascular risk predictor. Measuring intima-media thickness of the CCA (C-IMT) is a well-evidenced tool for the detection of early stages of atherosclerosis. We aimed here to study both serum chemerin and hs-CRP as markers of subclinical atherosclerosis in Egyptian patients with type 2 diabetes, who are angiographically free of coronary artery disease (CAD). Subjects and methods: This cross-sectional study was conducted on 180 subjects divided into two groups: Group A included 90 type 2 diabetic patients without CAD and group B including 90 nondiabetic control subjects. All study subjects were having normal coronary angiography. Serum chemerin, homeostasis model assessment for insulin resistance (HOMA-IR), glycated haemoglobin (HbA1c), lipid profile, hs-CRP as well as C-IMT were assessed in all study subjects. Results: There was a statistically significant difference between the 2 groups regarding serum chemerin level, HOMA-IR, hs-CRP and C-IMT; being higher in the diabetic patients than in the control group ( p = 0.006, 0.024, 0.040 and <0.001, respectively). There was positive correlation between serum chemerin level and waist-to-hip ratio (WHR), HOMA-IR, hs-CRP and C-IMT. Carotid intima-media thickness was positively correlated with patients’ WHR, blood pressure, HbA1c, diabetes duration as well as hs-CRP, and negatively correlated with ankle-brachial index (ABI). Linear regression analysis showed that HbA1c, serum chemerin and hs-CRP were independently affecting C-IMT. Serum hs-CRP was positively correlated with HbA1c and HOMA-IR ( p = 0.006 and 0.032, respectively), and negatively correlated with HDL-cholesterol level ( p = 0.018). Conclusion: Both serum chemerin and hs-CRP could be considered as markers of subclinical atherosclerosis, and hence, may be utilized for the early detection of macrovascular disease, in Egyptian patients with type 2 diabetes.
url https://doi.org/10.1177/2042018816637312
work_keys_str_mv AT nagwaalachine serumchemerinandhighsensitivitycreactiveproteinasmarkersofsubclinicalatherosclerosisinegyptianpatientswithtype2diabetes
AT abdelazizelnekiedy serumchemerinandhighsensitivitycreactiveproteinasmarkersofsubclinicalatherosclerosisinegyptianpatientswithtype2diabetes
AT magdyhelmymegallaa serumchemerinandhighsensitivitycreactiveproteinasmarkersofsubclinicalatherosclerosisinegyptianpatientswithtype2diabetes
AT gihaneikhalil serumchemerinandhighsensitivitycreactiveproteinasmarkersofsubclinicalatherosclerosisinegyptianpatientswithtype2diabetes
AT mohamedasadaka serumchemerinandhighsensitivitycreactiveproteinasmarkersofsubclinicalatherosclerosisinegyptianpatientswithtype2diabetes
AT kamelhrohoma serumchemerinandhighsensitivitycreactiveproteinasmarkersofsubclinicalatherosclerosisinegyptianpatientswithtype2diabetes
AT hebaskassab serumchemerinandhighsensitivitycreactiveproteinasmarkersofsubclinicalatherosclerosisinegyptianpatientswithtype2diabetes
_version_ 1724605371959476224